• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人血小板上非5-羟色胺能[3H]酮色林结合位点的鉴定及其在5-羟色胺释放中的作用。

Identification of non-serotonergic [3H]ketanserin binding sites on human platelets and their role in serotonin release.

作者信息

Leysen J E, Gommeren W, Janssen P A

机构信息

Department of Biochemical Pharmacology, Janssen Research Foundation, Beerse, Belgium.

出版信息

Eur J Pharmacol. 1991 Jan 25;206(1):39-45. doi: 10.1016/0922-4106(91)90144-7.

DOI:10.1016/0922-4106(91)90144-7
PMID:2065715
Abstract

[3H]Ketanserin was found to label (besides a low amount of 5-HT2 receptors) non-serotonergic binding sites on human platelet membranes. The latter binding was detected in the presence of excess of the 5-HT2 antagonist BW501, and was potently inhibited by tetrabenazine. [3H]Ketanserin revealed a KD value = 19 +/- 4 nM and a Bmax = 425 +/- 82 fmol/10(9) platelets for these binding sites. [3H]Ketanserin binding in the presence of BW501 was inhibited by the tetrabenazine derivative RO-4-1284 (IC50 = 1.4 nM), tetrabenazine (IC50 = 8.6 nM) and the ketanserin derivatives R 71,278 (IC50 = 6.3 nM), R 47,288 (IC50 = 17 nM) and R 71,428 (IC50 = 100 nM). Ketanserin revealed an IC50 = 32 nM. The drugs were found to trigger the release of 3H from [3H]5-HT-loaded human platelets in superfusion experiments in vitro. The amount of 3H released by the drugs correlated with their binding affinities for the non-serotonergic sites. The non-serotonergic [3H]ketanserin binding sites on human platelets and their possible role in triggering monoamine release corresponded to the properties of non-serotonergic ketanserin binding sites previously characterized in rat striatum. The possible role of the action of ketanserin on the non-serotonergic sites in the reported partial reduction by ketanserin of the monoamine content in cardiovascular tissues is discussed.

摘要

已发现[3H]酮色林除标记少量5-HT2受体外,还能标记人血小板膜上的非5-羟色胺能结合位点。后者的结合在存在过量5-HT2拮抗剂BW501的情况下被检测到,并且被丁苯那嗪强烈抑制。对于这些结合位点,[3H]酮色林显示出KD值=19±4 nM,Bmax=425±82 fmol/10(9)个血小板。在BW501存在下的[3H]酮色林结合被丁苯那嗪衍生物RO-4-1284(IC50=1.4 nM)、丁苯那嗪(IC50=8.6 nM)以及酮色林衍生物R 71,278(IC50=6.3 nM)、R 47,288(IC50=17 nM)和R 71,428(IC50=100 nM)抑制。酮色林显示出IC50=32 nM。在体外灌注实验中,发现这些药物能触发[3H]5-羟色胺负载的人血小板释放3H。药物释放的3H量与其对非5-羟色胺能位点的结合亲和力相关。人血小板上的非5-羟色胺能[3H]酮色林结合位点及其在触发单胺释放中的可能作用与先前在大鼠纹状体中表征的非5-羟色胺能酮色林结合位点的特性相符。讨论了酮色林作用于非5-羟色胺能位点在报告的酮色林使心血管组织中单胺含量部分降低中的可能作用。

相似文献

1
Identification of non-serotonergic [3H]ketanserin binding sites on human platelets and their role in serotonin release.人血小板上非5-羟色胺能[3H]酮色林结合位点的鉴定及其在5-羟色胺释放中的作用。
Eur J Pharmacol. 1991 Jan 25;206(1):39-45. doi: 10.1016/0922-4106(91)90144-7.
2
Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.大鼠脑中与神经末梢及血小板相关的非5-羟色胺能[3H]酮色林结合位点的鉴定;与酮色林和丁苯那嗪类药物诱导的生物胺代谢产物释放的关系。
J Pharmacol Exp Ther. 1988 Jan;244(1):310-21.
3
Non-serotonergic 3H-ketanserin binding sites in human platelets: characteristics and interaction with calcium antagonists.人血小板中的非5-羟色胺能3H-酮色林结合位点:特性及与钙拮抗剂的相互作用
Pharmacol Res. 1992 Sep;26(2):187-99. doi: 10.1016/s1043-6618(05)80132-x.
4
Binding of [3H]dihydrotetrabenazine and [125I]azidoiodoketanserin photoaffinity labeling of the monoamine transporter of platelet 5-HT organelles.[3H]二氢丁苯那嗪与[125I]叠氮碘酮色林对血小板5-羟色胺细胞器单胺转运体的光亲和标记结合。
Eur J Pharmacol. 1990 Sep 4;186(1):95-104. doi: 10.1016/0014-2999(90)94064-5.
5
Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles.
Mol Pharmacol. 1988 Jun;33(6):672-7.
6
Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserin.使用[3H]酮色林证明猫血小板上的S2受体结合位点。
Eur J Pharmacol. 1983 Mar 18;88(1):125-30. doi: 10.1016/0014-2999(83)90401-6.
7
Characterization of 5-hydroxytryptamine binding sites in the plasma membrane of pig blood platelets.猪血小板细胞膜中5-羟色胺结合位点的特性研究
J Neural Transm. 1985;61(3-4):193-218. doi: 10.1007/BF01251913.
8
Binding characteristics of [3H]ketanserin for serotonin-2 receptor in the rabbit platelet.[3H]酮色林与兔血小板中血清素-2受体的结合特性
J Pharmacobiodyn. 1991 Aug;14(8):461-6. doi: 10.1248/bpb1978.14.461.
9
Human platelet dense granules: improved isolation and preliminary characterization of [3H]-serotonin uptake and tetrabenazine-displaceable [3H]-ketanserin binding.人血小板致密颗粒:[3H] - 5-羟色胺摄取及丁苯那嗪可置换的[3H] - 酮色林结合的改进分离与初步表征
Life Sci. 1990;46(24):1755-64. doi: 10.1016/0024-3205(90)90139-i.
10
Uptake of 5-hydroxytryptamine in blood platelets and its inhibition by drugs: role of plasma membrane and granular storage.5-羟色胺在血小板中的摄取及其药物抑制作用:质膜和颗粒储存的作用
J Pharm Pharmacol. 1979 May;31(5):284-9. doi: 10.1111/j.2042-7158.1979.tb13502.x.

引用本文的文献

1
Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms.色胺酮通过增强认知灵活性来抑制雌性大鼠的活动限制型厌食症:5-HT1A 和 5-HT2A 受体机制的贡献。
Mol Psychiatry. 2024 Oct;29(10):3291-3304. doi: 10.1038/s41380-024-02575-9. Epub 2024 Apr 27.
2
Human platelet 5-HT2 receptor binding sites re-evaluated: a criticism of current techniques [corrected].人类血小板5-羟色胺2型受体结合位点的重新评估:对当前技术的批评[已修正]
J Neural Transm Gen Sect. 1993;92(1):11-24. doi: 10.1007/BF01245158.
3
Serotonin-induced platelet intracellular calcium mobilization in depressed patients.
抑郁症患者中血清素诱导的血小板细胞内钙动员
Psychopharmacology (Berl). 1994 Jan;113(3-4):322-7. doi: 10.1007/BF02245204.